[Biomax] BC000111b : Multiple organ cancer tissue array, including TNM, clinical stage and pathology grade, 39 cases/39 cores, replacing BC000111a

[Biomax] BC000111b : Multiple organ cancer tissue array, including TNM, clinical stage and pathology grade, 39 cases/39 cores, replacing BC000111a

 

Microarray Panel	Multiple organ carcinoma tissue microarray, containing 39 cases of carcinoma from 13 types of organ (cerebrum, esophagus, stomach, colon, lung, pancreas, kidney, bladder, thyroid, uterine cervix, breast, prostate and gallbladder), single core per case
Cores	39	BC000111b H&E
Cases	39
Row number	5
Column number	8
Core Diameter (mm)	2
Thickness (µm)	5
Tissue Array Type	FFPE
Species	Human
Applications	54
Notes	1. TMA slides were sectioned and stored at 4°C and may not be fresh cut, but still suitable for IHC. Please request fresh cut if experiment involves phospho-specific antibodies, RNA studies, FISH or ISH, etc. A minimum of 3 slides per TMA must be purchased to cover the cost of trimming for fresh sectioning. 2. Most TMA slides were not coated with an extra layer of paraffin (tissue cores can be easily seen on the glass). To prevent tissue detachment during antigen retrieval, unbaked slides must be baked for at least 30 to 120 minutes at 60°C. before putting into xylene for de-paraffinization. Baked slides were sent out baked for 2 hours. In the following specsheet,“*” means invalid core; “-” means no applicable or negative in IHC markers.Mouseover and click individual cores to view high resolution images. BC000111b C6 No.:22 Age:68 Sex:M Organ/Anatomic Site:Bladder Pathology diagnosis:Low grade urothelial carcinoma TNM:T2N0M0 Grade:- Stage:II Type:Malignant Legend: Bla - Bladder, Bre - Breast, Cer - Cerebrum, Col - Colon, Eso - Esophagus, Gal - Gallbladder, Kid - Kidney, Lun - Lung, Pan - Pancreas, Pro - Prostate, Sto - Stomach, Thy - Thyroid gland, Ute - Uterine cervix, — - —  - Malignant tumor,  - Malignant tumor (stage I),  - Malignant tumor (stage IB),  - Malignant tumor (stage II),  - Malignant tumor (stage IIA),  - Malignant tumor (stage IIB),  - Malignant tumor (stage IIBI),  - Malignant tumor (stage III),  - Malignant tumor (stage IIIB),  - Malignant tumor (stage IV) Specification Sheet (Sortable), tissue IDs are available in exported Excel files. Pos. No. Age Sex Organ/Anatomic Site Pathology diagnosis TNM Grade Stage Type Image A1 1 37 M Cerebrum Astrocytoma - 1--2 - Malignant A2 2 45 F Cerebrum Astrocytoma - 2 - Malignant A3 3 57 M Cerebrum Astrocytoma - 2 - Malignant A4 4 59 M Esophagus Squamous cell carcinoma T3N0M0 2 IIA Malignant A5 5 50 M Esophagus Squamous cell carcinoma T3N0M0 2 IIA Malignant A6 6 61 M Esophagus Squamous cell carcinoma T2N0M0 2 IIA Malignant A7 7 66 M Stomach Adenocarcinoma T2N0M0 3 IB Malignant A8 8 69 M Stomach Adenocarcinoma T2N0M0 3 IB Malignant B1 9 50 F Stomach Adenocarcinoma T3N0M0 2--3 II Malignant B2 10 45 M Colon Mucinous adenocarcinoma T4N2M0 2 III Malignant B3 11 60 M Colon Adenocarcinoma T4N0M0 3 IIBI Malignant B4 12 37 F Colon Signet ring cell carcinoma T3N0M0 - IIA Malignant B5 13 43 F Lung Adenocarcinoma T2N2M0 2 IIA Malignant B6 14 41 M Lung Adenocarcinoma T2N0M0 1 I Malignant B7 15 42 M Lung Adenocarcinoma T2N0M0 3 I Malignant B8 16 52 M Pancreas Duct adenocarcinoma T3N0M0 2 II Malignant C1 17 57 M Pancreas Duct adenocarcinoma T3N0M0 3 II Malignant C2 18 77 F Pancreas Duct adenocarcinoma T2N0M0 2 I Malignant C3 19 54 M Kidney Clear cell carcinoma T1N0M0 1 I Malignant C4 20 30 F Kidney Clear cell carcinoma T3N0M1 1 IV Malignant C5 21 70 M Kidney Clear cell carcinoma T2N1M0 2 III Malignant C6 22 68 M Bladder Low grade urothelial carcinoma T2N0M0 - II Malignant C7 23 50 M Bladder High grade urothelial carcinoma T2N0M0 - II Malignant C8 24 57 M Bladder Low grade urothelial carcinoma T2aN0M0 - II Malignant D1 25 36 F Thyroid gland Papillary carcinoma T2N0M0 - I Malignant D2 26 19 F Thyroid gland Papillary carcinoma T3N0M0 - I Malignant D3 27 45 F Uterine cervix Squamous cell carcinoma T3N1M0 3 IIIB Malignant D4 28 48 F Uterine cervix Squamous cell carcinoma T3N0M0 3 II Malignant D5 29 49 F Uterine cervix Squamous cell carcinoma T1bN0M0 2 IB Malignant D6 30 42 F Breast Invasive ductal carcinoma T3N0M0 2 IIB Malignant D7 31 37 F Breast Invasive ductal carcinoma T2N1M0 2 IIB Malignant D8 32 51 F Breast Invasive ductal carcinoma T2N1M0 2 IIB Malignant E1 33 82 M Prostate Adenocarcinoma (Gleason grade 4; Gleason score 3+4) T3N0M0 2--3 III Malignant E2 34 76 M Prostate Adenocarcinoma (Gleason grade 3; Gleason score 3+3) T2N0M0 2 III Malignant E3 35 70 F Gallbladder Adenocarcinoma T1aN0M0 2 I Malignant E4 36 68 M Gallbladder Adenocarcinoma T2N0M0 2--3 II Malignant E5 37 66 M Gallbladder Adenocarcinoma T2N0M0 2--3 II Malignant E6 38 53 F Gallbladder Adenocarcinoma T3N0M0 3 IIA Malignant E7 39 54 M Gallbladder Adenocarcinoma T2N1M0 2 III Malignant E8 40 — — — — - 0 42 M Adrenal gland Pheochromocytoma (tissue marker) - Malignant